Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Epigenetic changes might protect occipital hair from male pattern baldness.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Genetic testing can help understand male pattern baldness.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Male mice with FGF5 mutations grow longer hair than females.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Hormones and neuropeptides affect hair growth, with androgens having opposite effects on beard and scalp hair.

Hair loss needs more research for better treatments.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Increased PPARGC1α relates to hair thinning in common baldness.